Skip to main content

Raleigh pharma raises $5M as phase 3 study begins

A Raleigh pharmaceutical company is raising money as it moves its lead drug into a late-stage study.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.